Commentary on “Applying CHW method to 2-in-1 design: gain or lose”

References

• Bai, X., and Q. Deng. 2019. Applying CHW method to 2-in-1 design: Gain or loss. Journal of Biopharmaceutical Statistics
   PubMed Web of Science ®Google Scholar
• Brannath, W., M. Bruckner, H. M. J. Hung, and A. Koch. 2013. Unblinded adaptive statistical information design based on clinical endpoint or biomarker. Statistics in Biopharmaceutical Research 5 (4):293–310. doi:10.1080/19466315.2013.791639.
   Web of Science ®Google Scholar
• Chen, C., K. Anderson, D. Mehrotra, E. Rubin, and A. Tse. 2018. A 2-in-1 phase 2/3 design for expedited oncology drug development. Contemporary Clinical Trials 64:238–242. doi:10.1016/j.cct.2017.09.006.
   PubMed Web of Science ®Google Scholar
• Cui, L., H. M. J. Hung, and S. Wang. 1999. Modification of sample size in group sequential clinical trial. Biometrics 55:853–857.
   PubMed Web of Science ®Google Scholar
• Cui, L., H. M. J. Hung, and S. J. Wang. 1997. Impact of changing sample size in a group sequential clinical trials. The Proceedings of American Statistical Association, Biopharmaceutical Section, Anaheim, CA, 52–57.
   Google Scholar
• Cui, L., and L. Zhang. 2019. On the efficiency of adaptive sample size design. Statistics in Medicine 28:933–944. doi:10.1002/sim8034.
   Google Scholar
• Cui, L., L. Zhang, and B. Yang. 2017. Optimal adaptive group sequential design with flexible timing of sample size determination. Contemporary Clinical Trials 63:8–12. doi:10.1016/j.cct.2017.04.005.
   PubMed Web of Science ®Google Scholar
• Gao, P., J. H. Ware, and C. Mehta. 2008. Sample size re-estimation for adaptive sequential design in clinical trials. Journal Of Biopharmaceutical Statistics 18:1184–1196. doi:10.1080/10543400802369053.
   PubMed Web of Science ®Google Scholar
• Hung, H. M. J., L. Cui, S. Wang, and J. Lawrence. 2005. Adaptive statistical inference following sample size modification based on interim review of effect size. Journal of Biopharmaceutical Statistics 15:693–706. doi:10.1081/BIP-200062855.
   PubMed Web of Science ®Google Scholar
• Hung, H. M. J., and R. T. ONeill. 2012. Paradigms for adaptive statistical information designs: Practical experiences and strategies. Statistics in Medicine 31:3011–3023. doi:10.1002/sim.5410.
   PubMed Web of Science ®Google Scholar
• Jennison, C., and B. W. Turnbull. 2003. Mid-course sample size modification in clinical trials based on the observed treatment effect. Statistics in Medicine 22:971–993. doi:10.1002/sim.1457.
   PubMed Web of Science ®Google Scholar
• Lawrence, J. 2002. Design of clinical trials using an adaptive test statistic. Pharmaceutical Statistics 1:87–105. doi:10.1002/pst.14.
   Google Scholar
• Lawrence, J., and H. M. J. Hung. 2003. Estimation and confidence interval after adjusting the maximum information. Biometrical Journal 45:143–152. doi:10.1002/bimj.200390001.
   Web of Science ®Google Scholar
• Lehmarcher, W., and G. Wassmer. 1999. Adaptive sample size calculations in group sequential trials. Biometrics 55:1286–1290.
   PubMed Web of Science ®Google Scholar
• Liu, G. L., R. Zhu, and L. Cui. 2008. Evaluating adaptive performance of flexible sample size design in a pre-determined interval of exploration for treatment difference. Statistics in Medicine 27:584–596. doi:10.1002/sim.2998.
   PubMed Web of Science ®Google Scholar
• Mehta, C., P. Bauer, M. Posch, and W. Brannath. 2007. Repeated confidence intervals for adaptive group sequential trials. Statistics in Medicine 26:5422–5543. doi:10.1002/sim.3062.
   PubMed Web of Science ®Google Scholar
• Tsiatis, A. A., and C. Mehta. 2003. ON the inefficiency of the adaptive design for monitoring clinical trials. Biometrika 90:367–378. doi:10.1093/biomet/90.2.367.
   Web of Science ®Google Scholar
• US Food and Drug Administration 2018. Adaptive designs for clinical trials of drugs and biologics - guidance for industry. FDA. Accessed March 5, 2019. https://www.fda.gov/downloads/drugs/guidances/ucm201790.pdf.
   Google Scholar
• Wang, S., H. M. J. Hung, Y. Tsong, and L. Cui. 2001. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials. Statistics in Medicine 20:1903–1912. doi:10.1002/sim.820.
   PubMed Web of Science ®Google Scholar
• Wang, S. J., P. Hua, and H. M. J. Hung. 2018. Evaluation of the extent of adaptation to sample size in clinical trials for cardiovascular and CNS diseases. Contemporary Clinical Trials 67:31–36. doi:10.1016/j.cct.2018.02.004.
   PubMed Web of Science ®Google Scholar
• Wu, X., and L. Cui. 2012. Group sequential and discretized sample size re-estimation designs: A comparison of flexibility. Statistics in Medicine 31:2844–2857. doi:10.1002/sim.5395.
   PubMed Web of Science ®Google Scholar
• Zhang, L., L. Cui, and B. Yang. 2016. Optimal flexible sample size design with robust power. Statistics in Medicine 35:3385–3396. doi:10.1002/sim.6931.
   PubMed Web of Science ®Google Scholar